Table 2

Differences in neoplasm-related deaths for patients with SLE and the general Spanish population for the period 2016–2019

Neoplasm-related deaths n (%)Mean age (years) (SD)
Non-SLESLEP valueNon-SLESLEP value
Total139 4409170.7 (13.5)64.8 (12.4)<0.001
SON127 080 (91.1)73 (80.2)0.00170.6 (13.3)63.9 (12.5)<0.001
HN12 360 (8.9)18 (19.8)0.00171.9 (15.5)68.3 (11.7)0.333
Malign neoplasm136 792 (98.1)90 (98.9)170.6 (13.5)64.9 (12.5)0.001
 Malign SON124 831 (89.5)72 (79.1)0.00370.5 (13.3)64 (12.6)<0.001
 Malign HN11 989 (8.6)18 (19.8)0.00171.7 (15.6)68.3 (11.7)0.366
Benign SON727 (0.5)00.59672.3 (13.5)
UB neoplasm1698 (1.2)00.63278.7 (13.8)
 UB SON1327 (1)0178.6 (14.7)
 UB HN371 (0,3)0179 (10.5)
In situ carcinoma186 (9.1)1 (1)0.12473.4 (12.4)570.188
  • Values in bold highlight statistically significant difference.

  • HN, haematological neoplasm; SON, solid organ neoplasm; UB, uncertain behaviour.